Dubber Corporation Limited (DUB.AX)
AUD 0.03
(13.79%)
AUD 0.03
(13.79%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -22.83 Million | -50.17 Million | -42.2 Million | -17.44 Million | -12.68 Million | -9.55 Million |
| Net Income | -40.72 Million | -69.19 Million | -84.1 Million | -31.69 Million | -18 Million | -9.64 Million |
| Depreciation & Amortization | 8.15 Million | 8.39 Million | 7.26 Million | 3.04 Million | 2.05 Million | 1.57 Million |
| Deferred income taxes | - | -19.87 Million | -25.74 Million | -21.9 Million | -9.01 Million | 2.03 Million |
| Stock-based compensation | 3.62 Million | 5.97 Million | 19.95 Million | 13.84 Million | 4.41 Million | 620.29 Thousand |
| Change in working capital | 423.64 Thousand | 3.17 Million | 15.38 Million | -2.51 Million | -1.03 Million | -2.65 Million |
| Other non-cash items | 5.69 Million | 21.33 Million | 25.04 Million | 21.77 Million | 8.9 Million | -1.47 Million |
| Investing Cash Flow | 2.41 Million | 322.43 Thousand | -40.22 Million | -12.58 Million | 1.45 Million | -2.54 Million |
| Investments in PPE | -3387.00 | -740.84 Thousand | -3.09 Million | -250.29 Thousand | -127.16 Thousand | -61.49 Thousand |
| Acquisitions | 750.00 | - | -6.95 Million | -12.34 Million | 67.31 Thousand | - |
| Investment purchases | - | - | -30.17 Million | -1.5 Million | 1.51 Million | -2.48 Million |
| Sales/Maturities of investments | - | 1.06 Million | 30.17 Million | 1.51 Million | 1.51 Million | - |
| Other Investing Activities | 2.42 Million | 1.06 Million | -30.17 Million | 14.36 Thousand | -1.51 Million | -2.48 Million |
| Financing Cash Flow | 29.03 Million | -1.93 Million | 105 Million | 47.46 Million | 10.07 Million | 26.04 Million |
| Debt repayment | -496.44 Thousand | -2.24 Million | -963.52 Thousand | -2.46 Million | -189.07 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -4.47 Million | -2.4 Million | -488.51 Thousand | -1.5 Million |
| Common Stock Issuance | 28.28 Million | 316.5 Thousand | 105.97 Million | 45.62 Million | 10.26 Million | 26.04 Million |
| Other Financing Activities | 28.54 Million | -2.24 Million | 105 Million | 48.58 Million | 10.07 Million | 1.5 Million |
| Accounts receivables | 875.74 Thousand | -1.65 Million | 16.7 Million | 4.3 Million | 4.99 Million | -2.65 Million |
| Accounts payables | -1.16 Million | 4.56 Million | -7.97 Million | -6.27 Million | -5.49 Million | 505.2 Thousand |
| Inventory | - | - | - | - | - | -677.65 Thousand |
| Other working capital | -452.09 Thousand | 268.2 Thousand | 6.66 Million | -544.37 Thousand | -538.01 Thousand | 172.45 Thousand |
| Cash at beginning of period | 2.02 Million | 54.38 Million | 32.04 Million | 18.4 Million | 19.61 Million | 5.67 Million |
| Cash at end of period | 10.64 Million | 2.86 Million | 54.38 Million | 32.04 Million | 18.4 Million | 19.61 Million |
| Capital Expenditure | -3387.00 | -740.84 Thousand | -3.09 Million | -250.29 Thousand | -127.16 Thousand | -61.49 Thousand |
| Effect of forex changes on cash | 1419.00 | 266.42 Thousand | -234.61 Thousand | 10.61 Thousand | -64.38 Thousand | -1466.00 |
| Net cash flow / Change in cash | 8.62 Million | -51.52 Million | 22.34 Million | 13.63 Million | -1.2 Million | 13.94 Million |
| Free Cash Flow | -22.83 Million | -50.92 Million | -45.3 Million | -17.69 Million | -12.81 Million | -9.61 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -18.57 Million | -40.72 Million | -22.14 Million | -32.12 Million | -69.19 Million | -37.06 Million |
| Depreciation & Amortization | 4.02 Million | 8.15 Million | 4.12 Million | 3.69 Million | 8.39 Million | 4.7 Million |
| Deferred income taxes | - | - | - | -9.99 Million | -19.87 Million | - |
| Stock-based compensation | 1.5 Million | - | 2.12 Million | 4.26 Million | 5.97 Million | 1.7 Million |
| Change in working capital | 423.64 Thousand | -229.97 Thousand | - | -1.38 Million | 3.17 Million | - |
| Other non-cash items | 1.21 Million | 26.56 Million | 14.85 Million | 12.04 Million | 21.33 Million | 15.36 Million |
| Investing Cash Flow | 1.14 Million | 2.41 Million | 1.26 Million | 966.54 Thousand | 322.43 Thousand | -644.1 Thousand |
| Investments in PPE | -2188.00 | -3387.00 | -1199.00 | -33.45 Thousand | -740.84 Thousand | -707.38 Thousand |
| Acquisitions | 750.00 | 750.00 | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 1 Million | 1.06 Million | 63.28 Thousand |
| Other Investing Activities | 1.15 Million | 2.42 Million | 1.27 Million | 1 Million | 1.06 Million | 288.28 Thousand |
| Financing Cash Flow | 20.26 Million | 28.52 Million | 8.77 Million | -1.37 Million | -1.93 Million | -551.3 Thousand |
| Debt repayment | -2.85 Million | -2.85 Million | -887.46 Thousand | - | -2.24 Million | -867.8 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 18.62 Million | 28.28 Million | 9.65 Million | - | 316.5 Thousand | 316.5 Thousand |
| Other Financing Activities | 20.26 Million | - | 9.65 Million | -1.37 Million | -2.24 Million | 316.5 Thousand |
| Accounts receivables | 875.74 Thousand | 1.38 Million | - | -1.65 Million | -1.65 Million | - |
| Accounts payables | - | -1.16 Million | - | - | 4.56 Million | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -452.09 Thousand | -452.09 Thousand | - | 268.2 Thousand | 268.2 Thousand | - |
| Cash at beginning of period | 1.48 Million | 2.86 Million | 2.86 Million | 26.72 Million | 54.38 Million | 54.38 Million |
| Cash at end of period | 10.64 Million | 10.64 Million | 1.6 Million | 2.86 Million | 2.86 Million | 26.72 Million |
| Capital Expenditure | -2188.00 | -3387.00 | -1199.00 | -33.45 Thousand | -740.84 Thousand | -707.38 Thousand |
| Effect of forex changes on cash | -321.00 | - | 1740.00 | 325.5 Thousand | 266.42 Thousand | -59.08 Thousand |
| Net cash flow / Change in cash | 9.16 Million | 7.78 Million | -1.25 Million | -23.86 Million | -51.52 Million | -27.66 Million |
| Free Cash Flow | -11.4 Million | -22.32 Million | -11.42 Million | -23.8 Million | -50.92 Million | -27.11 Million |
603380
2102
603912
9958
600515
TORNTPHARM